Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Clinicopathological and p53 Gene Alteration Comparison between Young and Older Patients with Gastric Cancer

  • Karim, Sajjad (Centre of Excellence in Genomic Medicine Research, King Abdulaziz University)
  • Published : 2014.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Differences in clinicopathological characteristics of gastric cancer (GC) between young and older patients are controversial and a matter of debate. Determining the statistical significance of clinicopathological information with respect to age might provide clues for better management and treatment ofGC. Materials and Methods: A total ofl03 Indiao GC patients were enrolled for study and specimens were classified according to the AjCC-TNM system. Patients were grouped into two age-wise categories, young patients (<40 years; n=13) and older patients (${\geq}40$ years, n=90). The clinicopathological features of both groups were retrospectively examined and compared. p53 alterations were analyzed by polymerase chain reaction-single strand conformational polymorphism and immunohistochemistry methods at gene and protein levels respectively. The cases were considered p53 over-expressed if it was present in more than 25% of the tumor cells and p53 alterations was correlated with the clinicopathological characteristics of the patients as well as etiological factors for GC in both groups. Results: We found significant association of young patients with cancer stage (p=0.01), and very strong association with histology grade (p=0.064) and poorly differentiated (p=0.051) state of GC. However, neither young nor elderly patients showed associations with location, gender, etiological factors and p53 expression and alteration. Overall the male-to-female ratio of GC patients was 3.12 and the value was higher in the young (5.5) than in the older group (2.91). Conclusions: Clinicopathological features of GC like caocer stage, cell differentiation and histological grades were significantly different among young and old age cohorts. We observed a male predominance among the young group that decreased significantly with advancing age. More awareness of GC onset is required to detect cancer at an early stage for successful treatment.

Keywords

References

  1. Al-Refaie WB, Hu CY, Pisters PW, Chang GJ (2011). Gastric adenocarcinoma in young patients: a population-based appraisal. Ann Surg Oncol, 18, 2800-7. https://doi.org/10.1245/s10434-011-1647-x
  2. Anderson WF, Camargo MC, Fraumeni JF Jr, et al (2010). Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA, 303, 1723-8. https://doi.org/10.1001/jama.2010.496
  3. Boldys H, Marek Ta, Wanezura P, Matusik P, Nowak A (2003). Even young patients with no alarm symptoms should undergo endoscopy for earlier diagnosis of gastric cancer. Endoscopy, 35, 61-7. https://doi.org/10.1055/s-2003-36414
  4. Choi JH, Chung HC, Yoo NC, et al (1996).Gastric cancer in young patients who underwent curative resection. Comparative study with older patients. Am J Clin Oncol, 19, 45-8. https://doi.org/10.1097/00000421-199602000-00010
  5. Chung HW, Noh SH, Lim JB (2010). Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol, 16, 256-63. https://doi.org/10.3748/wjg.v16.i2.256
  6. Crew KD, Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol, 12, 354-62.
  7. Dhobi MA, Wani KA, Parray FQ, et al (2013). Gastric cancer in young patients. Int J Surg Oncol, [Epub ahead of print]
  8. Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11.
  9. Guggenheim DE, Shah MA (2013). Gastric cancer epidemiology and risk factors. J Surg Oncol, 107, 230-6. https://doi.org/10.1002/jso.23262
  10. Haruma K, Ito M, Kohmoto K, et al (2000). Expression of cell cycle regulators and growth factor/receptor systems in gastric carcinoma in young adults: association with Helicobacter pylori infection. Int J Mol Med, 5, 185-90.
  11. Hajmanoochehri F, Mohammadi N, Nasirian N, Hosseinkhani M (2013). Patho-epidemiological features of esophageal and gastric cancers in an endemic region: a 20-year retrospective study. Asian Pac J Cancer Prev, 14, 3491-7. https://doi.org/10.7314/APJCP.2013.14.6.3491
  12. IARC Biennial Report (2001), International Agency For Research on Cancer, WHO, Lyon, France, 2000-2001; Vol. 41.
  13. Isobe T, Hashimoto T, Kizaki J, et al (2013). Characteristics and prognosis of gastric cancer in young patients. Oncol Rep, 30, 43-9.
  14. Karim S, Arif Ali (2009). Correlation of p53 overexpression and alteration in p53 gene detected by PCR-SSCP in adenocarcinoma of gastric cancer patients from India. World J Gastroenterology, 15, 1381-7. https://doi.org/10.3748/wjg.15.1381
  15. Karim S, Mirza Z, Naseer MI, Al-Qahtani MH, Ali A (2013). Clinicopathological characteristics and chronology of p53 expression in the development of gastric cancer. Hepatogastroenterology, 60, 2113-8.
  16. Kitamura K, Yamaguchi T, Yamamoto K, et al (1996). Clinicopathological analysis of gastric cancer in young adults. Hepato-gastroenterology, 43, 1273-80.
  17. Koea JB, Karpeh MS, Brennam MF (2000). Gastric cancer in young patents: demographic, clinicopathological, and prognostic factor in 92 patients. Ann Surg Oncol, 7, 346-51. https://doi.org/10.1007/s10434-000-0346-9
  18. Kulig J, Popiela T, Kolodziejczyk P, et al (2008). Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients. Langenbecks Arch Surg, 393, 37-43
  19. Lauren P (1965). The two histological main types of gastric carcinoma, diffuse and so-called intestinal-types carcinoma. An attempt at histochemical classification. Acta Pathol Microbiol Scand, 64, 31-9.
  20. Li Q, Hao X, Zhang D (1999). Gastric cancer in the young. Zhonghua Zhong Liu Za Zhi, 21, 224-6.
  21. Lim S, Lee HS, Kim HS, Kim Y, Kim WH (2003). Alteration of E-cadherin-mediated adhesion protein is common, but Microsatellite instability is uncommon in young age gastric cancers. Histopathology, 42, 128-36. https://doi.org/10.1046/j.1365-2559.2003.01546.x
  22. Liu Y, Kaneko S, Sobue T (2004). Trends in reported incidences of gastric cancer by tumour location, from 1975 to 1989 in Japan. Int J Epidemiol, 33, 808-15. https://doi.org/10.1093/ije/dyh053
  23. Medina-Franco H, Heslin MJ, Cortes-Gonzalez R (2000). Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study. Ann Surg Oncol, 7, 515-9. https://doi.org/10.1007/s10434-000-0515-x
  24. Nakamura T, Yao T, Niho Y, Tsuneyoshi M (1999). A Clinicopathological study in young patients with gastric carcinoma. J Surg Oncol, 71, 212-9.
  25. Nguyen DK, Maggard-Gibbons M (2013). Age, poverty, acculturation, and gastric cancer. Surgery, 154, 444-52. https://doi.org/10.1016/j.surg.2013.05.017
  26. Parkin DM, Bray FMD, Ferlay J, Pisani P (2005). Global cancer statistics. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  27. Piso P, Bektas H, Werner U, et al (2002). Comparison between treatment results for gastric cancer in younger and elderly patients. Zentralbl Chir, 127, 270-4. https://doi.org/10.1055/s-2002-31553
  28. Quispe D, Ruiz E, Celis J, Berrospie S, Payet E (2000). Gastric cancer in young patients. Rev Gastroentrol Peru, 20, 384-94.
  29. Rao DN, Ganesh B (1998). Estimate of cancer incidence in India in 1991. Indian J Cancer, 35, 10-8.
  30. Rugge M, Shiao YH, Busatto G, et al (2000). The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with cardiac location Mol Pathol, 53, 207-10. https://doi.org/10.1136/mp.53.4.207
  31. Sadeghi RN, Damavand B, Vahedi M, et al (2013). Detection of p53 Common Intron Polymorphisms in Patients with Gastritis Lesions from Iran. Asian Pac J Cancer Prev, 14, 91-6. https://doi.org/10.7314/APJCP.2013.14.1.91
  32. Saito H, Takaya S, Fukumoto Y, et al (2012). Clinicopathologic characteristics and prognosis of gastric cancer in young patients. Yonago Acta Med, 55, 57-61.
  33. Santoro R, Carboni F, Lepiane P, Ettorre GM, Santoro E (2007). Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg, 94, 737-42. https://doi.org/10.1002/bjs.5600
  34. Seker M, Aksoy S, Ozdemir NY, Uncu D, Zengin N (2013). Clinicopathologic features of gastric cancer in young patients. Saudi J Gastroenterol, 19, 258-61. https://doi.org/10.4103/1319-3767.120876
  35. Simsa J, Leffler J, Hoch J, Linke Z, Padr R (2004). Gastric cancer in young patients - is there any hope for them? Acta Chir Belg, 104, 673-6
  36. Sipponen P, Correa P (2002). Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer, 5, 213-9. https://doi.org/10.1007/s101200200037
  37. Smith BR, Stabile BE (2009). Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young. Arch Surg, 144, 506-10 https://doi.org/10.1001/archsurg.2009.77
  38. Sobin LH, Wittekind CH (2002). TNM: Classification of Malignant Tumors. 6th Ed. New York, NY: Wiley-Liss.
  39. Tso Pl, Bringaze WL 3rd, Dauterive AH, Correa P, Cohn I Jr (1987). Gastric carcinoma in the young. Cancer, 59, 1362-5. https://doi.org/10.1002/1097-0142(19870401)59:7<1362::AID-CNCR2820590722>3.0.CO;2-0
  40. Yokota T, Takahashi N, Teshima S, et al (1999). Early gastric cancer in the young: clinicopathological study. Aust NZ J Surg, 69, 443-6. https://doi.org/10.1046/j.1440-1622.1999.01553.x

Cited by

  1. Anti-Proliferation Effects and Molecular Mechanisms of Action of Tetramethypyrazine on Human SGC-7901 Gastric Carcinoma Cells vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3581
  2. Cancer Informatics: Profiling Age-Related Epigenetic Markers of Stomach Adenocarcinoma in Young and Old Subjects vol.14, pp.1176-9351, 2015, https://doi.org/10.4137/CIN.S16912
  3. Association of a p53 Codon 72 Gene Polymorphism with Environmental Factors and Risk of Lung Cancer: a Case Control Study in Mizoram and Manipur, a High Incidence Region in North East India vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10653
  4. Prognostic Significance of p53 in Gastric Cancer: a Meta-Analysis vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.327
  5. Risk Factors and Epidemiology of Gastric Cancer in Pakistan vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4821
  6. Expression of mutant p53 in oral squamous cell carcinoma is correlated with the effectiveness of intra-arterial chemotherapy pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3651
  7. Molecular alterations in gastric cancer with special reference to the early-onset subtype vol.22, pp.8, 2016, https://doi.org/10.3748/wjg.v22.i8.2460
  8. Expression profile of E-cadherin, estrogen receptors, and P53 in early-onset gastric cancers vol.5, pp.12, 2016, https://doi.org/10.1002/cam4.931
  9. Detection of gastric cancer and its histological type based on iodine concentration in spectral CT vol.18, pp.1, 2018, https://doi.org/10.1186/s40644-018-0176-2